Header Logo
Last Name

Daniel J Carr

TitleProf,George L Cross Rsrch
InstitutionUniversity of Oklahoma Health Sciences Center
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    T32EY023202     (CARR, DANIEL J)May 1, 2014 - Apr 30, 2019
    Cellular & Molecular Cascades in Vision Research
    Role: Principal Investigator

    R01EY021238     (CARR, DANIEL J)Dec 1, 2010 - Nov 30, 2020
    Corneal Lymphatics & Adaptive Immunity
    Role: Principal Investigator

    R21EY018834     (CARR, DANIEL J)Jan 1, 2009 - Dec 31, 2010
    Ocular Lymphangiogenesis
    Role: Principal Investigator

    R01AI067309     (CARR, DANIEL J)Jul 1, 2007 - Jun 30, 2011
    The Role of CXCL9 in Genital HSV-2 Infection
    Role: Principal Investigator

    R21EY015566     (CARR, DANIEL J)Apr 1, 2004 - Mar 31, 2007
    Anti-Viral Gene Delivery in the Nervous System
    Role: Principal Investigator

    R01AI053108     (CARR, DANIEL J)Apr 1, 2003 - Dec 31, 2022
    The Neuroimmunology of Viral Infection
    Role: Principal Investigator

    R01EY012409     (CARR, DANIEL J)Dec 1, 1998 - Nov 30, 2002
    Role: Principal Investigator

    R01NS035470     (CARR, DANIEL J)Jul 1, 1996 - Oct 31, 1999
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Royer DJ, Hendrix JF, Larabee CM, Reagan AM, Sjoelund VH, Robertson DM, Carr DJJ. Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection. Mucosal Immunol. 2019 Jan 22. PMID: 30670763.
      View in: PubMed
    2. Royer DJ, Elliott MH, Le YZ, Carr DJJ. Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II. Invest Ophthalmol Vis Sci. 2018 03 01; 59(3):1512-1522. PMID: 29625473.
      View in: PubMed
    3. Royer DJ, Carr DJJ. Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?" J Virol. 2017 12 01; 91(23). PMID: 29138328.
      View in: PubMed
    4. Carr DJJ. Herpes Simplex Virus 1, Macrophages, and the Cornea. J Virol. 2017 11 01; 91(21). PMID: 29030534.
      View in: PubMed
    5. Chucair-Elliott AJ, Gurung HR, Carr MM, Carr DJJ. Colony Stimulating Factor-1 Receptor Expressing Cells Infiltrating the Cornea Control Corneal Nerve Degeneration in Response to HSV-1 Infection. Invest Ophthalmol Vis Sci. 2017 09 01; 58(11):4670-4682. PMID: 28903153.
      View in: PubMed
    6. Royer DJ, Carr MM, Gurung HR, Halford WP, Carr DJJ. The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. J Immunol. 2017 09 01; 199(5):1898-1911. PMID: 28760885.
      View in: PubMed
    7. Menendez CM, Carr DJJ. Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells. J Neuroinflammation. 2017 06 23; 14(1):124. PMID: 28645309.
      View in: PubMed
    8. Royer DJ, Carr MM, Chucair-Elliott AJ, Halford WP, Carr DJ. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. J Virol. 2017 04 01; 91(7). PMID: 28122977.
      View in: PubMed
    9. Menendez CM, Carr DJJ. Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection. J Neuroimmunol. 2017 07 15; 308:43-49. PMID: 28302316.
      View in: PubMed
    10. Chucair-Elliott AJ, Carr MM, Carr DJJ. Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system. J Leukoc Biol. 2017 05; 101(5):1253-1261. PMID: 28115476.
      View in: PubMed
    11. Zander RA, Guthmiller JJ, Graham AC, Pope RL, Burke BE, Carr DJ, Butler NS. Type I Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria. PLoS Pathog. 2016 Oct; 12(10):e1005945. PMID: 27732671.
      View in: PubMed
    12. Gurung HR, Carr MM, Carr DJ. Cornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1. Immunol Cell Biol. 2017 01; 95(1):87-98. PMID: 27577867.
      View in: PubMed
    13. Royer DJ, Conrady CD, Carr DJ. Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNa/ß Defense Pathways. J Immunol. 2016 09 15; 197(6):2338-52. PMID: 27511736; PMCID: PMC5011016 [Available on 09/15/17].
    14. Chucair-Elliott AJ, Jinkins J, Carr MM, Carr DJ. IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection. Am J Pathol. 2016 10; 186(10):2665-78. PMID: 27497323.
      View in: PubMed
    15. Menendez CM, Jinkins JK, Carr DJ. Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency. J Immunol. 2016 08 15; 197(4):1262-75. PMID: 27357149; PMCID: PMC4975964 [Available on 08/15/17].
    16. Royer DJ, Gurung HR, Jinkins JK, Geltz JJ, Wu JL, Halford WP, Carr DJJ. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity. J Virol. 2016 06 01; 90(11):5514-5529. PMID: 27030264.
      View in: PubMed
    17. Drevets P, Chucair-Elliott A, Shrestha P, Jinkins J, Karamichos D, Carr DJ. The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation. Graefes Arch Clin Exp Ophthalmol. 2015 Oct; 253(10):1721-8. PMID: 26047535; PMCID: PMC4573349 [Available on 10/01/16].
    18. Royer DJ, Zheng M, Conrady CD, Carr DJ. Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils. Invest Ophthalmol Vis Sci. 2015 Jun; 56(6):3763-75. PMID: 26066745; PMCID: PMC4468912.
    19. Chucair-Elliott AJ, Zheng M, Carr DJ. Degeneration and regeneration of corneal nerves in response to HSV-1 infection. Invest Ophthalmol Vis Sci. 2015 Jan 13; 56(2):1097-107. PMID: 25587055; PMCID: PMC4329947.
    20. Bryant-Hudson KM, Gurung HR, Zheng M, Carr DJ. Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection. J Virol. 2014 Dec; 88(24):14451-7. PMID: 25297992; PMCID: PMC4249127.
    21. Li X, Gu X, Boyce TM, Zheng M, Reagan AM, Qi H, Mandal N, Cohen AW, Callegan MC, Carr DJ, Elliott MH. Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation. Invest Ophthalmol Vis Sci. 2014 Aug 26; 55(10):6224-34. PMID: 25159208; PMCID: PMC4183075.
    22. Kroll CM, Zheng M, Carr DJ. Enhanced resistance of CXCR3 deficient mice to ocular HSV-1 infection is due to control of replication in the brain ependyma. J Neuroimmunol. 2014 Nov 15; 276(1-2):219-23. PMID: 25139013; PMCID: PMC4253723.
    23. Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014 Sep; 62(9):1418-34. PMID: 24807365; PMCID: PMC4107000.
    24. Chan AY, Mann SN, Chen H, Stone DU, Carr DJ, Mandal NA. Sphingolipids in ocular inflammation. Adv Exp Med Biol. 2014; 801:623-9. PMID: 24664751.
      View in: PubMed
    25. Bryant-Hudson KM, Chucair-Elliott AJ, Conrady CD, Cohen A, Zheng M, Carr DJJ. HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response. Am J Pathol. 2013 Oct; 183(4):1233-1242. PMID: 23911821; PMCID: PMC3791868.
    26. Bryant-Hudson K, Conrady CD, Carr DJ. Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host? Prog Retin Eye Res. 2013 Sep; 36:281-91. PMID: 23876483; PMCID: PMC3759604.
    27. Fung KY, Mangan NE, Cumming H, Horvat JC, Mayall JR, Stifter SA, De Weerd N, Roisman LC, Rossjohn J, Robertson SA, Schjenken JE, Parker B, Gargett CE, Nguyen HP, Carr DJ, Hansbro PM, Hertzog PJ. Interferon-e protects the female reproductive tract from viral and bacterial infection. Science. 2013 Mar 01; 339(6123):1088-92. PMID: 23449591; PMCID: PMC3617553.
    28. Conrady CD, Zheng M, van Rooijen N, Drevets DA, Royer D, Alleman A, Carr DJ. Microglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitis. J Immunol. 2013 Mar 15; 190(6):2807-17. PMID: 23382563; PMCID: PMC3594081.
    29. Bryant-Hudson KM, Carr DJ. CXCL1-deficient mice are highly sensitive to pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection. Invest Ophthalmol Vis Sci. 2012 Oct 01; 53(11):6785-92. PMID: 22952118; PMCID: PMC3462609.
    30. Conrady CD, Zheng M, Stone DU, Carr DJ. CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis. J Immunol. 2012 Jul 01; 189(1):425-32. PMID: 22649204; PMCID: PMC3382000.
    31. Zheng M, Conrady CD, Ward JM, Bryant-Hudson KM, Carr DJ. Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites. J Virol. 2012 Jul; 86(13):7454-8. PMID: 22532684; PMCID: PMC3416341.
    32. Bryant-Hudson KM, Carr DJ. PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection. Clin Dev Immunol. 2012; 2012:924619. PMID: 22474484; PMCID: PMC3299487.
    33. Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog. 2011 Oct; 7(10):e1002278. PMID: 21998580; PMCID: PMC3188529.
    34. Wuest TR, Thapa M, Zheng M, Carr DJ. CXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice. J Neuroimmunol. 2011 May; 234(1-2):103-8. PMID: 21470697; PMCID: PMC3092799.
    35. Conrady CD, Jones H, Zheng M, Carr DJ. A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of Leukocytes. J Biomed Res. 2011 Mar; 25(2):111-119. PMID: 21709805.
      View in: PubMed
    36. Conrady CD, Halford WP, Carr DJ. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J Virol. 2011 Feb; 85(4):1625-33. PMID: 21147921; PMCID: PMC3028887.
    37. Wuest TR, Carr DJ. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med. 2010 Jan 18; 207(1):101-15. PMID: 20026662; PMCID: PMC2812544.
    38. Conrady CD, Drevets DA, Carr DJ. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J Neuroimmunol. 2010 Mar 30; 220(1-2):1-9. PMID: 19819030; PMCID: PMC2835842.
    39. Thapa M, Carr DJ. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol. 2009 Sep; 83(18):9486-501. PMID: 19587047; PMCID: PMC2738229.
    40. Conrady CD, Thapa M, Wuest T, Carr DJ. Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice. J Immunol. 2009 Mar 15; 182(6):3678-87. PMID: 19265146; PMCID: PMC2652688.
    41. Wuest TR, Carr DJ. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J Immunol. 2008 Dec 01; 181(11):7985-93. PMID: 19017990; PMCID: PMC2596651.
    42. Carr DJ, Austin BA, Halford WP, Stuart PM. Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways. J Neuroimmunol. 2009 Jan 03; 206(1-2):39-43. PMID: 19042034; PMCID: PMC2626643.
    43. Muse M, Kane JA, Carr DJ, Farber JM, Lane TE. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis. Virology. 2008 Dec 20; 382(2):132-44. PMID: 18973912; PMCID: PMC2643215.
    44. Thapa M, Carr DJ. Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J Virol. 2008 Oct; 82(20):10295-301. PMID: 18684827; PMCID: PMC2566256.
    45. Welner RS, Pelayo R, Nagai Y, Garrett KP, Wuest TR, Carr DJ, Borghesi LA, Farrar MA, Kincade PW. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood. 2008 Nov 01; 112(9):3753-61. PMID: 18552210; PMCID: PMC2572801.
    46. Templeton A, Nguyen G, Ash JD, Straub RH, Carr DJ. Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection. J Neuroimmunol. 2008 Jun 15; 197(1):37-46. PMID: 18495255; PMCID: PMC2435389.
    47. Wuest TR, Carr DJ. The role of chemokines during herpes simplex virus-1 infection. Front Biosci. 2008 May 01; 13:4862-72. PMID: 18508551; PMCID: PMC2430744.
    48. Carr DJ, Wuest T, Ash J. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J Interferon Cytokine Res. 2008 Apr; 28(4):245-51. PMID: 18439102; PMCID: PMC2396780.
    49. Thapa M, Welner RS, Pelayo R, Carr DJ. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol. 2008 Jan 15; 180(2):1098-106. PMID: 18178850; PMCID: PMC2185792.
    50. Austin BA, Halford WP, Williams BR, Carr DJ. Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea. J Immunol. 2007 Apr 15; 178(8):5166-72. PMID: 17404299; PMCID: PMC1865505.
    51. Wuest T, Farber J, Luster A, Carr DJ. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol. 2006 Oct; 243(2):83-9. PMID: 17296171; PMCID: PMC1839954.
    52. Thapa M, Kuziel WA, Carr DJ. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol. 2007 Apr; 81(8):3704-13. PMID: 17267483; PMCID: PMC1866094.
    53. Wuest T, Austin BA, Uematsu S, Thapa M, Akira S, Carr DJ. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J Neuroimmunol. 2006 Oct; 179(1-2):46-52. PMID: 16884784; PMCID: PMC1586219.
    54. Carr DJ, Wuest T, Tomanek L, Silverman RH, Williams BR. The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection. Immunology. 2006 Aug; 118(4):520-6. PMID: 16895559; PMCID: PMC1539097.
    55. Austin BA, James CM, Härle P, Carr DJ. Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biol Proced Online. 2006; 8:55-62. PMID: 16900260; PMCID: PMC1489265.
    56. Halford WP, Weisend C, Grace J, Soboleski M, Carr DJ, Balliet JW, Imai Y, Margolis TP, Gebhardt BM. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol J. 2006 Jun 09; 3:44. PMID: 16764725; PMCID: PMC1557838.
    57. Austin BA, Halford W, Silverman RH, Williams BR, Carr DJ. OAS and PKR are not required for the antiviral effect of Ad:IFN-gamma against acute HSV-1 in primary trigeminal ganglia cultures. J Interferon Cytokine Res. 2006 Apr; 26(4):220-5. PMID: 16704298; PMCID: PMC1472294.
    58. Carr DJ, Ash J, Lane TE, Kuziel WA. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol. 2006 Mar; 87(Pt 3):489-99. PMID: 16476970; PMCID: PMC1479868.
    59. Carr DJ, Tomanek L. Herpes simplex virus and the chemokines that mediate the inflammation. Curr Top Microbiol Immunol. 2006; 303:47-65. PMID: 16570856; PMCID: PMC4076168.
    60. Carr DJ, Campbell IL. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system. Viral Immunol. 2006; 19(4):741-6. PMID: 17201669; PMCID: PMC1766944.
    61. Austin BA, James C, Silverman RH, Carr DJ. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J Immunol. 2005 Jul 15; 175(2):1100-6. PMID: 16002711.
      View in: PubMed
    62. Carr DJ, Tomanek L, Silverman RH, Campbell IL, Williams BR. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J Virol. 2005 Jul; 79(14):9341-5. PMID: 15994831; PMCID: PMC1168756.
    63. Wickham S, Lu B, Ash J, Carr DJ. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J Neuroimmunol. 2005 May; 162(1-2):51-9. PMID: 15833359.
      View in: PubMed
    64. Härle P, Möbius D, Carr DJ, Schölmerich J, Straub RH. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum. 2005 Apr; 52(4):1305-13. PMID: 15818682.
      View in: PubMed
    65. Al-Khatib K, Williams BR, Silverman RH, Halford W, Carr DJ. Dichotomy between survival and lytic gene expression in RNase L- and PKR-deficient mice transduced with an adenoviral vector expressing murine IFN-beta following ocular HSV-1 infection. Exp Eye Res. 2005 Feb; 80(2):167-73. PMID: 15670795.
      View in: PubMed
    66. John-Philip B, Carr DJ. Transfection of Mülller cells with type I interferon transgenes: resistance to HSV-1 infection. Methods Mol Med. 2005; 116:221-32. PMID: 16000865.
      View in: PubMed
    67. Al-Khatib K, Williams BR, Silverman RH, Halford W, Carr DJ. Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. J Immunol. 2004 May 01; 172(9):5638-47. PMID: 15100308; PMCID: PMC4060620.
    68. Wickham S, Ash J, Lane TE, Carr DJ. Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection. Immunol Res. 2004; 30(2):191-200. PMID: 15477660; PMCID: PMC4060602.
    69. Härle P, Carr DJ. Large-scale generation of plasmids that express type I interferon. Methods Mol Biol. 2004; 249:1-6. PMID: 14573886.
      View in: PubMed
    70. Carr DJ, Chodosh J, Ash J, Lane TE. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol. 2003 Sep; 77(18):10037-46. PMID: 12941914; PMCID: PMC224594.
    71. Al-khatib K, Williams BR, Silverman RH, Halford W, Carr DJ. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2',5'-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology. 2003 Aug 15; 313(1):126-35. PMID: 12951027.
      View in: PubMed
    72. Carr DJ, Al-khatib K, James CM, Silverman R. Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J Neuroimmunol. 2003 Aug; 141(1-2):40-6. PMID: 12965252; PMCID: PMC4060623.
    73. Al-Khatib K, Campbell IL, Carr DJ. Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice. J Neuroimmunol. 2002 Nov; 132(1-2):41-8. PMID: 12417432.
      View in: PubMed
    74. Härle P, Cull V, Guo L, Papin J, Lawson C, Carr DJ. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res. 2002 Oct; 56(1):39-49. PMID: 12323398.
      View in: PubMed
    75. Carr DJ, Noisakran S. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon. J Virol. 2002 Sep; 76(18):9398-406. PMID: 12186922; PMCID: PMC136437.
    76. Al-Khatib K, Williams BR, Silverman RH, Halford WP, Carr DJ. Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta. J Interferon Cytokine Res. 2002 Aug; 22(8):861-71. PMID: 12396725.
      View in: PubMed
    77. Härle P, Cull V, Agbaga MP, Silverman R, Williams BR, James C, Carr DJ. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J Virol. 2002 Jul; 76(13):6558-67. PMID: 12050368; PMCID: PMC136290.
    78. Carr DJ, Ash J, Al-Khatib K, Campbell IL. Unforeseen consequences of IL-12 expression in the eye of GFAP-IL12 transgenic mice following herpes simplex virus type 1 infection. DNA Cell Biol. 2002 May-Jun; 21(5-6):467-73. PMID: 12167250.
      View in: PubMed
    79. Härle P, Sainz B, Carr DJ, Halford WP. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology. 2002 Feb 15; 293(2):295-304. PMID: 11886249.
      View in: PubMed
    80. Carr DJ, Härle P, Gebhardt BM. The immune response to ocular herpes simplex virus type 1 infection. Exp Biol Med (Maywood). 2001 May; 226(5):353-66. PMID: 11393165.
      View in: PubMed
    Carr's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description